463 related articles for article (PubMed ID: 24157562)
21. Antithrombotic treatment of cerebrovascular disease.
Oczkowski WJ; Turpie AG
Baillieres Clin Haematol; 1990 Jul; 3(3):781-813. PubMed ID: 2271790
[TBL] [Abstract][Full Text] [Related]
22. Preventing recurrent cerebrovascular events in patients with stroke or transient ischemic attack: the current data.
Bergman D
J Am Acad Nurse Pract; 2011 Dec; 23(12):659-66. PubMed ID: 22145656
[TBL] [Abstract][Full Text] [Related]
23. Clinical inquiries. What is the best management for patients who have a TIA while on aspirin therapy?
Ahmed N; Coffey JB; Oh R
J Fam Pract; 2006 Jul; 55(7):627-8. PubMed ID: 16822451
[TBL] [Abstract][Full Text] [Related]
24. Anticoagulants versus antiplatelet therapy for preventing stroke in patients with nonrheumatic atrial fibrillation and a history of stroke or transient ischemic attack.
Saxena R; Koudstaal P
Cochrane Database Syst Rev; 2004 Oct; (4):CD000187. PubMed ID: 15494992
[TBL] [Abstract][Full Text] [Related]
25. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
Sztriha LK; Vécsei L
Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.
Eikelboom JW; Hart RG
Am J Hematol; 2012 May; 87 Suppl 1():S100-7. PubMed ID: 22389052
[TBL] [Abstract][Full Text] [Related]
27. Preventing strokes: the assessment and management of people with transient ischaemic attack.
Gommans J; Barber PA; Fink J
N Z Med J; 2009 Apr; 122(1293):3556. PubMed ID: 19448791
[TBL] [Abstract][Full Text] [Related]
28. Secondary prevention by stroke subtype: a nationwide follow-up study in 46 108 patients after acute ischaemic stroke.
Kim D; Lee SH; Joon Kim B; Jung KH; Yu KH; Lee BC; Roh JK;
Eur Heart J; 2013 Sep; 34(35):2760-7. PubMed ID: 23729692
[TBL] [Abstract][Full Text] [Related]
29. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
Audebert HJ; Schenk B; Tietz V; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2008; 26(2):171-7. PubMed ID: 18628615
[TBL] [Abstract][Full Text] [Related]
30. [Cerebral infarction].
Uchiyama S
Nihon Rinsho; 2006 Nov; 64(11):2039-44. PubMed ID: 17087294
[TBL] [Abstract][Full Text] [Related]
31. Antithrombotic and interventional treatment options in cardioembolic transient ischaemic attack and ischaemic stroke.
McCabe DJ; Rakhit RD
J Neurol Neurosurg Psychiatry; 2007 Jan; 78(1):14-24. PubMed ID: 17172564
[TBL] [Abstract][Full Text] [Related]
32. Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1.
Gorin L; Fauchier L; Nonin E; de Labriolle A; Haguenoer K; Cosnay P; Babuty D; Charbonnier B
Thromb Haemost; 2010 Apr; 103(4):833-40. PubMed ID: 20135077
[TBL] [Abstract][Full Text] [Related]
33. Filling the gap between science & clinical practice: prevention of stroke recurrence.
Russolillo A; Di Minno MN; Tufano A; Prisco D; Di Minno G
Thromb Res; 2012 Jan; 129(1):3-8. PubMed ID: 21907395
[TBL] [Abstract][Full Text] [Related]
34. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
35. Transient ischemic attack as a medical emergency.
Okada Y
Front Neurol Neurosci; 2014; 33():19-29. PubMed ID: 24157554
[TBL] [Abstract][Full Text] [Related]
36. Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.
Hankey GJ; Eikelboom JW
Lancet Neurol; 2010 Mar; 9(3):273-84. PubMed ID: 20170841
[TBL] [Abstract][Full Text] [Related]
37. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
Diener HC
Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
[TBL] [Abstract][Full Text] [Related]
38. Clopidogrel hydrogen sulphate for atrial fibrillation.
Garg N; Rajpurohit N; Flaker G
Expert Opin Pharmacother; 2011 Aug; 12(11):1781-7. PubMed ID: 21663525
[TBL] [Abstract][Full Text] [Related]
39. Rationale, design and baseline data of a randomized, double-blind, controlled trial comparing two antithrombotic regimens (a fixed-dose combination of extended-release dipyridamole plus ASA with clopidogrel) and telmisartan versus placebo in patients with strokes: the Prevention Regimen for Effectively Avoiding Second Strokes Trial (PRoFESS).
Diener HC; Sacco R; Yusuf S; ;
Cerebrovasc Dis; 2007; 23(5-6):368-80. PubMed ID: 17337887
[TBL] [Abstract][Full Text] [Related]
40. Initial management of suspected transient cerebral ischaemia and stroke in primary care: implications of recent research.
Lasserson DS
Postgrad Med J; 2009 Aug; 85(1006):422-7. PubMed ID: 19633008
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
